clinical trial · NCT00307060
MK0954A-264 Filter Study (0954A-264)(COMPLETED)
Organon and Co·phase3·completed·n = 274
Mild to Severe HypertensionMK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weekslosartan / Duration of Treatment: 6 weeks
brief summary
To compare the blood pressure lowering efficacy, safety and tolerability of a combination drug to a single drug taken once daily in patients with uncontrolled blood pressure following a 4-week filter on the single therapy product.
started
Dec 1, 2004
primary completion
Jun 1, 2005
completion
Jun 2, 2005
last updated
Aug 15, 2024
official title
A Randomized, Double-Blind, Parallel-Filter Study to Evaluate the Antihypertensive Efficacy and Safety of Losartan-HCTZ Combination as Compared to Losartan Monotherapy in Patients With Essential Hypertension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol